EUCTR2006-004320-36-IT进行中（未招募）不适用
Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration - ND
AZIENDA OSPEDALIERA SENESE0 个研究点开始时间: 2007年5月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- neovascular age-related macular degeneration
- •- age > 55
- •- Visual loss <4/10
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- previous ocular infections
- •- intravitreal hemoragies
研究者
相似试验
撤回
3 期
Intravitreal Bevacizumab for Inflammatory Neovascular MembranesVogt Koyanagi Harada DiseaseSerpiginous ChoroiditisMultifocal ChoroiditisNCT00407121Asociación para Evitar la Ceguera en México
已完成
不适用
Efficacy of PreOperative Bevacizumab for Diabetic Eye DiseaseProliferative Diabetic RetinopathyNCT01041690Cairo University19
已完成
不适用
Intravitreal Bevacizumab (Avastin) therapy for Proliferative Diabetic Retinopathydiabetic retinopathy.Retinal disorders in diseases classified elsewhereIRCT138903314232N1Vice chancellor for research; Babol university of medical sciences39
已完成
不适用
Intravitreal bevacizumab(Avastin) for macular edema secondary to uveitis: 1 year results of a prospective pilot studyMacular edema secondary to uveitis.Other specified retinal disordersIRCT138902113846N1Shiraz University of Medical Sciences30
招募中
不适用
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesionsJPRN-UMIN000020916Keio University, School of Medicine1,000